New insights into the association between non-alcoholic fatty liver disease and atherosclerosis.
作者信息
Valencia-Rodríguez Alejandro, Vera-Barajas Alfonso, Barranco-Fragoso Beatriz, Kúsulas-Delint Deyanira, Qi Xingshun, Méndez-Sánchez Nahum
机构信息
Liver Research Unit, Medica Sur Clinic & Foundation, Mexico City, Mexico.
Department of Gastroenterology, National Medical Center "20 Noviembre", Mexico City, Mexico.
出版信息
Ann Transl Med. 2019 Dec;7(Suppl 8):S300. doi: 10.21037/atm.2019.11.13.
Abstract
摘要
相似文献
1
New insights into the association between non-alcoholic fatty liver disease and atherosclerosis.非酒精性脂肪性肝病与动脉粥样硬化之间关联的新见解。
Ann Transl Med. 2019 Dec;7(Suppl 8):S300. doi: 10.21037/atm.2019.11.13.
2
Oxidative stress: New insights on the association of non-alcoholic fatty liver disease and atherosclerosis.氧化应激：非酒精性脂肪性肝病与动脉粥样硬化关联的新见解
World J Hepatol. 2015 Jun 8;7(10):1325-36. doi: 10.4254/wjh.v7.i10.1325.
3
Association between non-alcoholic fatty liver disease and subclinical coronary atherosclerosis: An observational cohort study.非酒精性脂肪性肝病与亚临床冠状动脉粥样硬化的相关性：一项观察性队列研究。
J Hepatol. 2018 May;68(5):1018-1024. doi: 10.1016/j.jhep.2017.12.012. Epub 2017 Dec 20.
4
Atherogenic index of plasma is a novel predictor of non-alcoholic fatty liver disease in obese participants: a cross-sectional study.血浆致动脉粥样硬化指数是肥胖参与者非酒精性脂肪肝的一个新的预测指标：一项横断面研究。
Lipids Health Dis. 2018 Dec 13;17(1):284. doi: 10.1186/s12944-018-0932-0.
5
[Non-alcoholic fatty liver disease and cardiovascular risk].[非酒精性脂肪性肝病与心血管风险]
Orv Hetil. 2008 Jul 13;149(28):1299-305. doi: 10.1556/OH.2008.28418.
6
Nonalcoholic fatty liver disease, association with cardiovascular disease and treatment. (I). Nonalcoholic fatty liver disease and its association with cardiovascular disease.非酒精性脂肪性肝病、与心血管疾病的关联及治疗。（一）非酒精性脂肪性肝病及其与心血管疾病的关联。
Clin Investig Arterioscler. 2017 May-Jun;29(3):141-148. doi: 10.1016/j.arteri.2016.06.003. Epub 2016 Sep 28.
7
Association of non-alcoholic fatty liver disease with impaired endothelial function by flow-mediated dilation: A meta-analysis.非酒精性脂肪性肝病与通过血流介导的血管舒张评估的内皮功能受损之间的关联：一项荟萃分析。
Hepatol Res. 2016 Mar;46(3):E165-73. doi: 10.1111/hepr.12554. Epub 2015 Aug 18.
8
Non-alcoholic fatty liver disease and subclinical atherosclerosis: A comparison of metabolically- versus genetically-driven excess fat hepatic storage.非酒精性脂肪性肝病与亚临床动脉粥样硬化：代谢性与遗传性肝内脂肪蓄积所致的对比。
Atherosclerosis. 2017 Feb;257:232-239. doi: 10.1016/j.atherosclerosis.2016.12.018. Epub 2016 Dec 21.
9
European Association for the Study of the Liver (EASL), European Association for the Study of Diabetes (EASD) and European Association for the Study of Obesity (EASO) clinical practice recommendations for the management of non-alcoholic fatty liver disease: evaluation of their application in people with Type 2 diabetes.欧洲肝脏研究学会（EASL）、欧洲糖尿病研究学会（EASD）和欧洲肥胖研究学会（EASO）非酒精性脂肪性肝病管理临床实践建议：评估其在 2 型糖尿病患者中的应用。
Diabet Med. 2018 Mar;35(3):368-375. doi: 10.1111/dme.13565. Epub 2018 Jan 10.
10
Non-parenchymal hepatic cell lipotoxicity and the coordinated progression of non-alcoholic fatty liver disease and atherosclerosis.非实质肝细胞核脂肪变性与非酒精性脂肪性肝病和动脉粥样硬化的协同进展。
Curr Opin Lipidol. 2018 Oct;29(5):417-422. doi: 10.1097/MOL.0000000000000535.
引用本文的文献
1
Associations of Metabolic Dysfunction-Associated Fatty Liver Disease With Peripheral Artery Disease: Prospective Analysis in the UK Biobank and ARIC Study.代谢功能障碍相关脂肪性肝病与外周动脉疾病的相关性：英国生物库和 ARIC 研究的前瞻性分析。
J Am Heart Assoc. 2024 Nov 19;13(22):e035265. doi: 10.1161/JAHA.124.035265. Epub 2024 Nov 15.
2
Anti-Inflammatory Oxysterol, Oxy210, Inhibits Atherosclerosis in Hyperlipidemic Mice and Inflammatory Responses of Vascular Cells.抗炎氧化固醇 Oxy210 抑制高脂血症小鼠动脉粥样硬化和血管细胞炎症反应。
Cells. 2024 Sep 30;13(19):1632. doi: 10.3390/cells13191632.
3
When the liver is in poor condition, so is the heart - cardiac remodelling in MASH mouse models.肝脏不好，心脏也好不到哪里去——MASH 小鼠模型中的心脏重构。
Clin Sci (Lond). 2024 Sep 18;138(18):1151-1171. doi: 10.1042/CS20240833.
4
From Liver to Brain: How MAFLD/MASLD Impacts Cognitive Function.从肝脏到大脑：MAFLD/MASLD 如何影响认知功能。
Med Sci Monit. 2024 Jan 29;30:e943417. doi: 10.12659/MSM.943417.
5
Effect of atorvastatin on subclinical atherosclerosis in virally-suppressed HIV-infected patients with CMV seropositivity: a randomized double-blind placebo-controlled trial.阿托伐他汀对巨细胞病毒血清阳性病毒抑制的 HIV 感染患者亚临床动脉粥样硬化的影响：一项随机、双盲、安慰剂对照试验。
F1000Res. 2023 Sep 15;10:151. doi: 10.12688/f1000research.28262.2. eCollection 2021.
6
Caspase-11 promotes high-fat diet-induced NAFLD by increasing glycolysis, OXPHOS, and pyroptosis in macrophages.半胱氨酸天冬氨酸蛋白酶 11 通过增加巨噬细胞中的糖酵解、氧化磷酸化和细胞焦亡来促进高脂肪饮食诱导的非酒精性脂肪性肝病。
Front Immunol. 2023 Jan 26;14:1113883. doi: 10.3389/fimmu.2023.1113883. eCollection 2023.
7
Correlation between gut microbiota diversity and psychogenic erectile dysfunction.肠道微生物群多样性与心因性勃起功能障碍之间的相关性。
Transl Androl Urol. 2021 Dec;10(12):4412-4421. doi: 10.21037/tau-21-915.
8
What is new in computer vision and artificial intelligence in medical image analysis applications.医学图像分析应用中的计算机视觉和人工智能有哪些新进展。
Quant Imaging Med Surg. 2021 Aug;11(8):3830-3853. doi: 10.21037/qims-20-1151.
9
Association and Prediction of Subclinical Atherosclerosis by Nonalcoholic Fatty Liver Disease in Asymptomatic Patients.无症状患者中非酒精性脂肪性肝病与亚临床动脉粥样硬化的关联及预测
Can J Gastroenterol Hepatol. 2020 Nov 30;2020:8820445. doi: 10.1155/2020/8820445. eCollection 2020.
10
Non-alcoholic fatty liver disease is associated with immune checkpoint inhibitor-based treatment response in patients with non-small cell lung cancer with liver metastases.非酒精性脂肪性肝病与伴有肝转移的非小细胞肺癌患者基于免疫检查点抑制剂的治疗反应相关。
Transl Lung Cancer Res. 2020 Apr;9(2):316-324. doi: 10.21037/tlcr.2020.04.15.
本文引用的文献
1
Atherosclerosis.动脉粥样硬化。
Nat Rev Dis Primers. 2019 Aug 16;5(1):56. doi: 10.1038/s41572-019-0106-z.
2
Dietary compounds have potential in controlling atherosclerosis by modulating macrophage cholesterol metabolism and inflammation via miRNA.膳食化合物通过微小RNA调节巨噬细胞胆固醇代谢和炎症，在控制动脉粥样硬化方面具有潜力。
NPJ Sci Food. 2018 Jul 25;2:13. doi: 10.1038/s41538-018-0022-8. eCollection 2018.
3
The association between liver fat and systemic calcified atherosclerosis.肝脏脂肪与全身性钙化动脉粥样硬化的关联。
J Vasc Surg. 2020 Jan;71(1):204-211.e4. doi: 10.1016/j.jvs.2019.03.044. Epub 2019 May 29.
4
Life-style-induced metabolic derangement and epigenetic changes promote diabetes and oxidative stress leading to NASH and atherosclerosis severity.生活方式引起的代谢紊乱和表观遗传变化会促进糖尿病和氧化应激，导致非酒精性脂肪性肝炎和动脉粥样硬化加重。
J Diabetes Metab Disord. 2018 Nov 29;17(2):381-391. doi: 10.1007/s40200-018-0378-y. eCollection 2018 Dec.
5
New Aspects of Lipotoxicity in Nonalcoholic Steatohepatitis.非酒精性脂肪性肝炎中脂毒性的新方面。
Int J Mol Sci. 2018 Jul 13;19(7):2034. doi: 10.3390/ijms19072034.
6
The management of incidental fatty liver found on imaging. What do we need to do?影像学检查发现的偶然型脂肪肝的管理。我们需要做什么？
Am J Gastroenterol. 2018 Sep;113(9):1274-1276. doi: 10.1038/s41395-018-0047-2. Epub 2018 Mar 16.
7
Nonalcoholic Fatty Liver Disease and Coronary Artery Calcification in a Northern Chinese Population: a Cross Sectional Study.非酒精性脂肪性肝病与冠状动脉钙化在北方中国人中的相关性：一项横断面研究。
Sci Rep. 2017 Aug 30;7(1):9933. doi: 10.1038/s41598-017-09851-5.
8
Nonalcoholic fatty liver disease is associated with coronary artery calcification: A systematic review and meta-analysis.非酒精性脂肪性肝病与冠状动脉钙化相关：一项系统评价和荟萃分析。
Dig Liver Dis. 2016 Dec;48(12):1410-1417. doi: 10.1016/j.dld.2016.09.002. Epub 2016 Sep 17.
9
Association of non-alcoholic fatty liver disease with major adverse cardiovascular events: A systematic review and meta-analysis.非酒精性脂肪性肝病与主要不良心血管事件的关联：系统评价和荟萃分析。
Sci Rep. 2016 Sep 16;6:33386. doi: 10.1038/srep33386.
10
Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: A meta-analysis.非酒精性脂肪性肝病与心血管疾病发病风险：荟萃分析。
J Hepatol. 2016 Sep;65(3):589-600. doi: 10.1016/j.jhep.2016.05.013. Epub 2016 May 17.
Zotero 插件